01 2Antares Pharma Inc.
02 6Antares Pharma, Inc
01 7No Action Indicated
02 1Voluntary Action Indicated
01 12025-01-16
02 12018-12-04
03 12017-02-27
04 22016-01-21
05 12012-09-06
06 12012-08-20
07 12009-07-14
01 2Ewing
02 5Minneapolis
03 1Minnetonka
01 8U.S.A
District Decision : No Action Indicated
Inspection End Date : 2025-01-16
City : Minnetonka
State : Minnesota
Country/Area : U.S.A
Zip : 55343
District :
Center :
Project Area : Drug Quality Assurance
District Decision : No Action Indicated
Inspection End Date : 2025-01-16
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-12-04
City : Minneapolis
State : MN
Country/Area : U.S.A
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : Voluntary Action Indicated
Inspection End Date : 2018-12-04
District Decision : No Action Indicated
Inspection End Date : 2017-02-27
City : Ewing
State : New Jersey
Country/Area : U.S.A
Zip : 8618
District :
Center :
Project Area : Bioresearch Monitoring
District Decision : No Action Indicated
Inspection End Date : 2017-02-27
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
City : Minneapolis
State : MN
Country/Area : U.S.A
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
City : Minneapolis
State : MN
Country/Area : U.S.A
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Postmarket Assurance: Devices
District Decision : No Action Indicated
Inspection End Date : 2016-01-21
District Decision : No Action Indicated
Inspection End Date : 2012-09-06
City : Minneapolis
State : MN
Country/Area : U.S.A
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2012-09-06
District Decision : No Action Indicated
Inspection End Date : 2012-08-20
City : Ewing
State : NJ
Country/Area : U.S.A
Zip : 08618-1433
District : NWJ
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2012-08-20
District Decision : No Action Indicated
Inspection End Date : 2009-07-14
City : Minneapolis
State : MN
Country/Area : U.S.A
Zip : 55447-5473
District : MIN
Center : CDRH
Project Area : Compliance: Devices
District Decision : No Action Indicated
Inspection End Date : 2009-07-14
Halozyme Therapeutics is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of ENHANZE DRUG PRODUCT bulk with DMF offered by Halozyme Therapeutics
